Report – Analysis of 2021 U.S FDA 483 GMP Observations

By Barbara W. Unger

In this report, you will see:

• The total number of FDA form 483 observations in FY2021
• Common themes from FDA 483 observations issued in FY2021
• How these observations compare to previous years’ observations